There is so much total bs going around with different companies propounding asinine cures with “light therapy” that I am incredibly dubious.
Photopharmics has completed enrollment of a Phase 3 clinical trial testing Celeste, its light therapy device for Parkinson’s disease, the company announced.
The ongoing Phase 3 trial (NCT04453033), dubbed Light for PD, has enrolled 350 participants with Parkinson’s, surpassing the initial target enrollment of 300 patients. Topline results from the trial are expected in the second quarter of 2026.
Hi CliveV, thank you for sharing this and reaching out. If you have any questions about ongoing research, our research team will be more than happy to help. You can email them via [email protected]
I don’t know about this clinical trial, but I was a “light therapy” nurse in Oxford for several years. I treated a huge variety of illnesses, with great success, so I hope this is trial is profitable - it’s certainly not ‘asinine’.